Bristol Myers Squibb Presents Landmark 10-12 months Observe-Up Information from CheckMate -067 Which Confirmed Continued Sturdy Lengthy-Time period Survival Profit with Opdivo ® plus Yervoy ® in Superior Melanoma By Investing.com
These information signify the longest reported median total survival from a Part…
